Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Related stories
Four ways to keep your energy bills down
SpaceX is moments away from monumental Starship launch
Nvidia launches record $150bn share buyback
Nvidia makes a statement with historic $150 billion buyback announcement
A pullback is brewing, say these strategists who have examined every drawdown since 1956
Why Europe’s centre will hold